Abstract | BACKGROUND: METHODS: The septic AKI model was constructed through lipopolysaccharide (LPS) treatment. PVT1 and miR-17-5p levels were measured using qRT-PCR analysis. The concentrations of inflammatory cytokines were determined with ELISA kits. Cell viability and apoptosis were assessed using CCK-8 assay and flow-cytometric analysis, respectively. Protein levels were examined using western blot assay. The targeting association between miR-17-5p and PVT1 was verified by dual- luciferase reporter, RIP and RNA pull-down assays. RESULTS: PVT1 level was elevated and miR-17-5p level was declined in septic AKI patients' serum and LPS-stimulated HK-2 cells. Cell viability was suppressed and cell apoptosis and inflammation were promoted after LPS treatment. PVT1 knockdown or miR-17-5p elevation restored LPS-mediated HK-2 cell injury. MiR-17-5p was sponged by PVT1, and its inhibition weakened the impact of PVT1 deficiency on LPS-mediated injury of HK-2 cells. In addition, PVT1 knockdown inactivated NF-κB pathway mediated by LPS treatment, but miR-17-5p inhibition further reversed this effect. CONCLUSION: PVT1 knockdown promoted cell viability, suppressed inflammatory response and apoptosis by regulating miR-17-5p expression and NF-κB pathway in LPS-stimulated HK-2 cells.
|
Authors | Wensheng Yuan, Xiaoqing Xiong, Jinlong Du, Qi Fan, Rong Wang, Xia Zhang |
Journal | International urology and nephrology
(Int Urol Nephrol)
Vol. 53
Issue 11
Pg. 2409-2419
(Nov 2021)
ISSN: 1573-2584 [Electronic] Netherlands |
PMID | 34089461
(Publication Type: Journal Article)
|
Copyright | © 2021. The Author(s), under exclusive licence to Springer Nature B.V. |
Chemical References |
- MIRN17 microRNA, human
- MicroRNAs
- NF-kappa B
- PVT1 long-non-coding RNA, human
- RNA, Long Noncoding
|
Topics |
- Acute Kidney Injury
(etiology)
- Cells, Cultured
- Humans
- MicroRNAs
(physiology)
- NF-kappa B
(physiology)
- RNA, Long Noncoding
(physiology)
- Sepsis
(etiology)
- Signal Transduction
(physiology)
- Time Factors
|